News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Horst_Sara_NASHVILLE_web.jpg)
Infections within first year of life predicted IBD
- Author:
- Amy Karon
The correlation was strongest for onset by age 10 years.
News
Induction trough levels predicted ustekinumab response in Crohn’s disease
- Author:
- Amy Karon
An ustekinumab trough level of 2.0 mcg/mL or higher distinguished responders from nonresponders with an area under the receiver operating curve of...
News
Clock gene disruption might underlie IBD
- Author:
- Amy Karon
Multiple clock genes showed reduced mRNA expression in inflamed and uninflamed intestinal mucosa and peripheral white blood cells from patients,...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Singal_Amit_DALLAS_web.jpg)
AGA Clinical Practice Update: Direct-acting antivirals and hepatocellular carcinoma
- Author:
- Amy Karon
For patients listed for liver transplantation, determine timing of DAA therapy on a case-by-case basis, consider regional wait times, availability...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/fibroids_uterine_web.jpg)
Ulipristal acetate tops placebo for uterine leiomyomas
- Author:
- Amy Karon
Significantly greater improvements in physical and social activities were seen with both ulipristal doses, compared with placebo, from baseline to...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/May-2018/van_Mulligen_Elise_ROTTERDAM_web.jpg)
Study compares tapering strategies in rheumatoid arthritis
- Author:
- Amy Karon
Cumulative rates of flare at 1 year were 33% with initial tapering of conventional synthetic DMARDs and 43% with initial TNF-inhibitor tapering (...
News
Induction trough levels predicted ustekinumab response in Crohn’s disease
- Author:
- Amy Karon
An ustekinumab trough level of 2.0 mcg/mL or higher distinguished responders from nonresponders with an area under the receiver operating curve of...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Mediterranean_Omega3_Diet_web.jpg)
Tailoring the Mediterranean diet for NAFLD
- Author:
- Amy Karon
Keys to success included providing recipes and meal planners, education on how lifestyle and diet contribute to NAFLD, and offering care in person...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Mease_Philip_WA3_web.jpg)
Positive psoriatic arthritis screens occur often in psoriasis patients
- Author:
- Amy Karon
In all, 12.4% of patients had a positive screen for possibly undiagnosed psoriatic arthritis but had never been diagnosed with the disease.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/genetic_research_web.jpg)
Gene therapy restored immunity in newly diagnosed SCID-X1
- Author:
- Amy Karon
In the phase 1/2 study, seven infants had normal immune cells 3-4 months after treatment, while the eighth infant responded after a gene therapy...
News
Look for functional esophageal disorders if GERD patients fail PPIs
- Author:
- Amy Karon
Fully 75% of PPI nonresponders had concurrent functional heartburn or reflux hypersensitivity.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Rubio Tapia_Alberto_NY_web.jpg)
No biopsy for 21% of adults with celiac disease
- Author:
- Amy Karon
The iCureCeliac Patient Powered Research Network is supported by the Patient-Centered Outcomes Research Institute. The investigators reported...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/139135_Hazen_Stanley_web.jpg)
Studies link TMAO to microbiome, reveal new heart disease target
- Author:
- Amy Karon
MIAMI – TMAO alters cholesterol and bile acid metabolism, upregulates inflammatory pathways, and promotes foam cell formation, all of which worsen...
News
AGA publishes care pathway for IBD in pregnancy
- Author:
- Amy Karon
Aminosalicylates, biologics, and immunomodulators can be continued during pregnancy and delivery.
News
AGA Clinical Practice Update: Switching between biologics and biosimilars in inflammatory bowel disease
- Author:
- Amy Karon
Two large studies have found switching to be safe, but FDA has not designated any biosimilar interchangeable.